5-Amino-1MQ in Canada: NNMT Research, Not a Peptide

5-Amino-1MQ appears in many searches about research peptides in Canada, but it is not a peptide. It is a small-molecule inhibitor of nicotinamide N-methyltransferase, commonly abbreviated NNMT. This distinction matters when identifying a material, selecting analytical methods and reading experimental literature.

This article covers laboratory research and documentation, not weight-loss advice, dosing, injection or personal-use protocols. FirstLabs research materials are not for human consumption.

What is NNMT?

NNMT is an enzyme that participates in nicotinamide metabolism. A 2017 study investigated small-molecule NNMT inhibitors, including their membrane permeability, selectivity and effects on cellular metabolites. The researchers examined cultured adipocytes and a diet-induced obesity mouse model.

An enzyme target explains a research hypothesis; it does not, by itself, establish the effects or safety of taking an inhibitor. A material’s identity, the experimental model and the measured endpoints all matter.

What the published study can—and cannot—show

The study examined a series of inhibitors, rather than proving a broad claim for every substance marketed under an NNMT-related name. When comparing results, identify which compound produced each observation and whether it came from a permeability assay, cultured cells or animals.

Findings from those models do not establish a safe or effective human weight-loss regimen. A before-and-after photograph, personal testimonial or online protocol is not a replacement for controlled evidence, and it cannot authenticate a particular supplier’s vial.

Is 5-Amino-1MQ a peptide?

No. Peptides and this small molecule belong to different chemical categories. A website’s catalogue grouping is not a chemical classification. For laboratory records, retain the full compound name and request identity documentation that describes the supplied chemical form.

Do not assume two products are analytically equivalent because they share a shortened name. Ask whether the report and label identify the same form and reporting basis, particularly when comparing labelled mass or measured quantity.

Comparing 5mg, 10mg and 50mg research listings

FirstLabs lists 5-Amino-1MQ 5mg, 10mg and 50mg as separate catalogue items. These sizes describe the offered material quantity; they are not personal dosing recommendations.

For each size, compare the actual label with the certificate and receiving record. A shared compound name or purity statement does not show that all sizes come from the same lot, that each vial was tested, or that measured content equals the label.

What to ask before a Canadian laboratory order

• Which chemical form and lot are being supplied?
• Can the certificate be connected to this size and the offered stock?
• What tests support identity, purity and quantity, and which are not reported?
• Are the method, units, report date and laboratory identifier visible?
• What storage, handling and shipping conditions apply to this material?

Review the published report library, then ask FirstLabs for any missing size- or lot-specific evidence. Do not infer refrigeration conditions or a shelf life from another compound’s guide; use material-specific documentation and the laboratory’s validated procedures.

Keep the evidence chain intact

Our batch traceability guide explains how to connect labels, reports and receiving records. The Canadian research guide library provides the wider sourcing checklist. Canadian dispatch alone does not identify the manufacturer or establish regulatory suitability.

Scientific source and scope

Neelakantan et al. (2017): Selective and membrane-permeable small molecule inhibitors of NNMT. The publication is used for enzyme-research context and the distinction between cell and animal evidence, not as validation of FirstLabs stock.

The cover is an illustrative assay-laboratory image, not a FirstLabs facility photograph or a result from the cited study. No human-use instructions are provided.